Peter Aaby Explained

Peter Aaby
Birth Date:6 November 1944
Birth Place:Lund, Sweden
Module:
Embed:yes
Awards:Novo Nordisk Prize (2000)

Peter Aaby (Danish, born 1944 in Lund, Sweden) is trained as an anthropologist but also holds a doctoral degree in medicine.[1] In 1978, Peter Aaby established the Bandim Health Project, a Health and Demographic Surveillance System site in Guinea-Bissau in West Africa, which he has run ever since.[2] In 2000, Peter Aaby was awarded the Novo Nordisk Prize, the most important Danish award within health research.

Aaby is credited for the discovery of non-specific effects of vaccines – i.e. effects of vaccines, which go beyond the specific protective effects against the targeted diseases.[3] The theory of non-specific effects of vaccines was established in 1991 and later documented in several trials on measles vaccine, BCG, oral polio vaccine, DTP vaccine and smallpox vaccine.[4] As a consequence of Aaby's work on non-specific effects of vaccines it has been recommended the WHO vaccination program in low income countries should be changed.[5] In 2008, WHO reviewed the evidence for non-specific effects of BCG vaccine, measles vaccine and DTP vaccine, and concluded that it would "keep a watch on the evidence of nonspecific effects of vaccination".[6]

See also

External links

Notes and References

  1. Book: Winkel. Klaus. Danskere i tropisk Afrika : fra slavehandler til bistandsarbejder. 2011. Klim. Århus. 978-8779559271. 1. udgave..
  2. Web site: Background. Bandim Health Project. SSI. 28 September 2015.
  3. Prentice. AM. Savy. M. Darboe. MK. Moore. SE. Commentary: Challenging public health orthodoxies--prophesy or heresy?. International Journal of Epidemiology. April 2009. 38. 2. 591–3. 19174540. 10.1093/ije/dyn363. 2663722.
  4. Benn. CS. Netea. MG. Selin. LK. Aaby. P. A small jab - a big effect: nonspecific immunomodulation by vaccines.. Trends in Immunology. September 2013. 34. 9. 431–9. 23680130. 10.1016/j.it.2013.04.004.
  5. Shann. F. Nonspecific effects of vaccines and the reduction of mortality in children.. Clinical Therapeutics. February 2013. 35. 2. 109–14. 23375475. 10.1016/j.clinthera.2013.01.007.
  6. Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008. 18689006 . 83 . 32 . Aug 2008. Wkly Epidemiol Rec. 287–92.